Analyst Ratings for Amphastar Pharmaceuticals Inc. (AMPH)

Updated: 2017-07-28

Analysts covering Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) have given it a consensus rating of Buy. Last month, AMPH received an average rating of Buy.

Of the 6 analysts covering the stock, 4 gave it a buy rating, 1 gave an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Several price targets were given for AMPH by the analysts covering the stock. The most optimistic price target was 22, implying potential capital gains of 27.24 percent. The most pessimistic price target was 16, implying a possible loss of -7.46 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. The average change in earnings estimates over the last 90 days is -13.39 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -22.11 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

The growth rate of AMPH's earnings is estimated by analysts to be 30.84 percent. Another measure frequently examined by investors is the PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. Many investors consider PEG ratios between 0 and 1 as preferrable, although it is frequently more appropriate to compare PEG ratios to the company's peers. AMPH has a PEG ratio of 2.95.

In the last 52-weeks, AMPH has achieved a high of 21.75 and a low of 12.05. Today's price is 43.49 percent above the 52-week low, and below the high by 20.51 percent. AMPH has a P/E ratio of 91. Investors typically compare the P/E ratio to a company's peers in the industry. The AMPH value stock report compares AMPH to some of its peers using value stock charts. The market cap of AMPH is $0.8059 billion. AMPH's next earnings release will be on 0000-00-00, which is days away.